The Effects of Glasses-Free 3D Training on Visual and Cognitive Function in Presbyopic Individuals
Condition(s) studied
Investigational drug(s) / intervention(s)
glasses-free 3D visual training: Trail group Conduct 15 minutes of naked-eye 3D vision training. Twice a day, five days a week. Control groups The subjects watched ordinary 2D videos for 15 minutes each time, all under the same lighting conditions. This was done twice a day, five days a week.
Study summary
This study aims to evaluate the effectiveness of glasses-free 3D visual training in improving visual function, visual comfort, and the application ability of visual functions in individuals with presbyopia. The research will assess changes in brain activity related to visual processing using Electroencephalogram(EEG)and Functional near-infrared spectroscopy(NIRS) before and after the training. By examining the impact of stereoscopic stimulation on the functional connectivity of brain regions, the study seeks to provide new insights into the rehabilitation of presbyopia and its underlying mechanisms. The goal is to offer a non-invasive and scientifically supported approach to improving presbyopia treatment, potentially advancing clinical practices and contributing to brain science and ophthalmology
Eligibility
Primary outcome measure(s)
- Amplitude of accommodation — Baseline and after 6 and 12 weeks of training
The push-up method combined with negative lens method was used. The measurements were completed by a comprehensive refractometer. It was performed according to the methods in Clinical Procedures for Ocular Examination 4th
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zhongshan Opthalmic Center, Sun Yat-sen University | Guangzhou | Guangdong |
More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06853691 on ClinicalTrials.gov ↗ ← All trials in China